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1726 Abstracts December 201350.4%) than non-PAD subjects (P < .001). PAD subjects were more likely
to have CAS (17.5% vs 3.4%), prior strokes (5.4% vs 1.6%), prior transient
ischemic attack (8.1% vs 3.2%), prior myocardial infarction (10.3% vs
3.6%), and prior coronary revascularization (14.8% vs 4.9%) than non-PAD
subjects (P < .001). There was a statistically signiﬁcant correlation between
decreasing ABI value and an increased prevalence of CAS, CAD, and CVD
(P < .001) (Fig). For example, patients with an ABI between 0.41 and 0.60
had a 26.4% incidence of CAS, which increased to 34.9% for those with an
ABI # 0.4. Even patients with a minimally decreased ABI (0.81-0.9) had
signiﬁcantly increased rates of vascular disease in other territories compared
with patients with normal ABIs.
Conclusions: The ABI value is directly and signiﬁcantly associated
with the prevalence of CAS, and with a history of CAD and CVD compli-
cations. These data support the use of the ABI as a noninvasive, inexpensive,
easily reproducible screening test that can reliably identify patients at
increased risk for cerebrovascular and cardiovascular complications.
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Objectives: The factors that lead to vein graft bypass restenosis and
ultimate clinical failure are incompletely understood. Cell cycle regulators,
such as the cyclin-dependent kinase inhibitor p27kip1, have been shown to
play critical roles in the regulation of vascular cell proliferation. Conte
et al and van Tiel et al, in fact, have identiﬁed a single nucleotide polymor-
phism (SNP) in the promoter region of the p27kip1 gene that is associated
with divergent clinical outcomes following lower extremity vein bypass
grafting and coronary artery stenting, respectively. Both clinical studies
demonstrated the p27kip1-838C>A SNP to be associated with signiﬁcantly
increased rates of clinical success compared with the -838CC and -838CA
genotypes. Although these represent highly signiﬁcant and clinically relevant
ﬁndings, these studies are primarily associative in nature and provide limited
insight into the mechanistic details. Here we aim to develop a model to
explore the precise mechanisms through which p27kip1 inﬂuences the local
vascular wall biology. There is a long history of divergent phenotypes of vein
graft remodeling secondary to alterations in ﬂow and wall shear stress.
Previous work in our laboratory using a novel vein graft model demon-
strated increased outward remodeling and decreased neointimal hyperplasia
in response to high-shear environments. Using high-throughput genomics,
we examined the speciﬁc genes and pathways that are closely associated with
p27kip1 and demonstrate differential expression in the divergent clinical
phenotypes seen in alternate ﬂow and shear stress conditions.
Methods: A rabbit carotid artery interposition graft with jugular vein
was placed and differential ﬂow states were created through outﬂow branch
ligation. Graft diameters and ﬂow rates were documented at the time of
implantation and harvest with ultrasound imaging. Vein grafts wereharvested at 2 hours, 1 day, 7 days, and 28 days following implantation.
Whole vessel homogenates were analyzed for gene expression using
a custom Agilent rabbit microarray. Next, ingenuity pathway analysis
(IPA) (Ingenuity, Redwood City, Calif) was employed to generate a list
of the closest 150 upstream and downstream genes in relation to p27kip1.
This list was cross-referenced to the rabbit array list to identify overlapping
genes, and this set of p27kip1-associated genes was analyzed for divergent
expression proﬁles between high and low shear conditions. These genes
were then further explored using IPA for ontologic analysis and creation
of signaling networks. dChip software (Harvard, Boston, Mass) was used
for clustering analysis and heat map generation.
Results: Outﬂow branch ligation resulted in an immediate 90% reduc-
tion in ﬂow on the ligated (low-ﬂow) vein graft side compared with the high
ﬂow side (3.1 6 0.4 vs 30.0 6 2.2 mL/min), and a 15-fold difference in
mean ﬂow rates was observed throughout the 28-day perfusion period
(P < .001). The reduction in ﬂow led to a robust hyperplastic response,
so that by 28 days a sevenfold increase in neointimal thickness was noted
in the low-ﬂow vs the high-ﬂow vein grafts (231 6 35 vs 36 6 18 mm;
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signaling pathways surrounding p27kip1. Nineteen probes sets within the
microarray were identiﬁed to be components of the p27 network (Table).
Sixteen of these genes encode nuclear proteins, the majority of which are
transcription regulators. The top functions of this gene set are cell cycle
regulation (13 genes), cellular growth and proliferation (17), gene expres-
sion (11), cellular development (14), and cell death and survival (12). A
supervised clustering analysis of these genes revealed two primary patterns of
gene expression, yielding two sets of genes with unique patterns of
expression (Fig 1, B). Cluster A was characterized by a more delayed but
prolonged upregulation compared with cluster B. Additionally, cluster B
exhibits greater upregulation at 7 days, and greater downregulation at 28
days in the high-ﬂow vs the low-ﬂow grafts, suggesting a global ﬂow-
dependent genomic response (Fig 2).
Conclusions: Vein graft remodeling is a complex process driven by
the interplay of local and systemic biology with mechanical forces. Despite
technological advances and improvements in surgical techniques, the precise
factors that determine whether a vein graft adopts an adaptive, outwardly
remodeling phenotype, vs an occlusive phenotype, are largely unknown. A
SNP of the p27kip1 gene, a key cell-cycle regulator, has recently been asso-
ciated with improved revascularization outcomes, yet the mechanisms
underlying this clinical observation remain undeﬁned. Here we attempt to
dissect the gene pathways and networks at play in shaping these divergent
outcomes. In the current analysis, we demonstrate that time-dependent
response to injury following vein graft implantation exerts the dominant
inﬂuence on alterations in the p27kip1 regulatory network. Although
changes in ﬂow result in marked differences in graft phenotype, this biologicTable. p27kip1 associated genes
Gene symbol Entrez gene name
ATG5 autophagy related 5
ATR ataxia telangiectasia and Rad3 related
CDK6 cyclin-dependent kinase 6
COPS5 COP9 signalosome subunit 5
DDB1 damage-speciﬁc DNA binding protein 1
DUSP9 dual speciﬁcity phosphatase 9
HMG20B high mobility group 20B
LHX1 LIM homeobox 1
MED1 mediator complex subunit 1
NCOA6 nuclear receptor coactivator 6
NRIP1 nuclear receptor interacting protein 1
PA2G4 proliferation-associated 2G4, 38kDa
PAK1IP1 PAK1 interacting protein 1
RAN RAN, member RAS oncogene family
RPL5 ribosomal protein L5
RPL23A ribosomal protein L23a
SMAD4 SMAD family member 4
TCF4 transcription factor4
UBE3A ubiquitin protein liqase E3Aimpact is mediated by a broad modulation of the p27kip1 pathway. Differ-
ence in gene expression between high and low ﬂow occurred predominately
in the 1- to 4-week timeframe, the time at which robust proliferation is
dominating the rapid growth of the intima. Intervention of the p27kip1
pathway may offer an important option for modulating cell cycle processes
that contribute to maladaptive vascular remodeling. In particular, cyto-
plasmic ribosomal and autophagy proteins appear to be the most promising
candidates for therapeutic intervention.
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Objectives: Thoracic endovascular aortic repair (TEVAR) is widely
used for treatment of traumatic aortic injury (TAI). Stent graft coverage
of the left subclavian artery (LSA) may be required in up to 40% of cases.
We evaluated the long-term effects of intentional LSA coverage on symp-
toms and return to normal activity in TAI patients, compared with a similarly
treated group without LSA coverage.
Methods: Patients were identiﬁed from a prospective institutional
trauma registry between September 2005 and July 2012. TAI was
conﬁrmed using computed tomographic angiography. The electronic
medical records, angiograms, and computed tomographic angiographies
were reviewed in a retrospective fashion. Personal or telephone interviews
were conducted using the SF-12v2 to assess quality of life. An additional
questionnaire was used to assess speciﬁc LSA symptoms and the ability to
return to normal activities. Data were analyzed by spearman rank correlation
and multiple linear and logistic regression analysis with appropriate transfor-
mations (SAS software).
Results: During the study period, 82 patients (57 male, mean age
49.5 6 20 years, mean ISS 34 6 10.0) underwent TEVAR for treatment
of TAI. Among them, 32 (39.5%) required left subclavian artery coverage
(LSAC), while 50 had their LSA uncovered (LSAU). We found no statisti-
cally signiﬁcant difference in SF-12 physical health scores (r ¼ .08; P ¼
.62) between LSAC and LSAU patients. LSAC patients had slightly better
mental health scores (r ¼ .62; P ¼ .037) than LSAU. LSAC patients did not
have increased likelihood of experiencing pain (r ¼ .0056; P ¼ .97),
numbness (r ¼ .12; P ¼ .45), parasthesia (r ¼ .11; P ¼ .48), fatigue
(r ¼ .066; P ¼ .69), or cramping (r ¼ .12; P ¼ .45). We found no
difference in ability to return to activities between groups. The mean
follow-up time was 3.35 years. Five (16%) of the LSAC patients expired
during the follow-up period due to unrelated causes.
Conclusions: Intentional coverage of the LSA during TEVAR for
TAI appears safe without compromising mental or physical health
outcomes. Furthermore, LSAC does not increase the long-term risk of
upper extremity symptoms or impairment of normal activities.Location Function
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